Successful management of infusion reaction accompanying the start of cetuximab therapy

Abstract

Cetuximab is a chimeric antibody registrated for the therapy of advanced colorectal carcinoma after failure of standard chemotherapy.

Keywords

• cetuximab
• colorectal carcinoma
• infusion reaction